38.0
Trevi Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
123
FY23:
87.5
FY24:
109
FY25:
192
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.52
FY22:
0.40
FY23:
1.86
FY24:
1.47
FY25:
1.78
Total assets
Change from FY21 to FY25
millions USD
FY21:
38.5
FY22:
123
FY23:
89.4
FY24:
111
FY25:
193
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
12.7
FY22:
13.4
FY23:
5.82
FY24:
10.5
FY25:
9.75
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.68
FY22:
2.16
FY23:
1.03
FY24:
0.75
FY25:
0.45
(positive)
Change from FY21 to FY25
millions USD
FY21:
17.1
FY22:
107
FY23:
82.5
FY24:
99.6
FY25:
183
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
38.5
FY22:
123
FY23:
89.4
FY24:
111
FY25:
193
All amounts in millions USD